
|Articles|November 10, 2012
Preclinical study suggests no harm to limbal stem cells from CXL
Preliminary results of a preclinical study investigating the effect of peripheral collagen crosslinking on the limbal stem cells provide some reassurance about the safety of the technique.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA guidance to help accelerate cell and gene therapies
2
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
3
The Residency Report: Cardiovascular risk scores as a window into ocular disease
4
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
5





















